Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors.

NCT00251797 is registered in ClinicalTrials.gov with University of New Mexico as lead sponsor.

NCT NCT00251797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00251797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors.
Lead sponsor
University of New Mexico
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2000
Completion date
June 30, 2006
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain and nervous system, cancer